Altrova Health Inc.
SSPLF
$0.03
$0.0010.04%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 73.47% | 92.87% | -55.08% | -31.34% | -40.36% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 90.91% | 92.87% | -50.66% | -30.12% | -40.36% |
| Operating Income | -65.90% | -92.87% | 52.23% | 33.00% | 40.36% |
| Income Before Tax | -54.51% | -54.52% | -248.55% | 37.71% | 52.45% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -54.51% | -54.52% | -248.55% | 37.71% | 52.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -54.51% | -54.52% | -248.55% | 37.71% | 52.45% |
| EBIT | -65.90% | -92.87% | 52.23% | 33.00% | 40.36% |
| EBITDA | -62.60% | -85.84% | 52.25% | 32.98% | 40.40% |
| EPS Basic | 3.45% | 31.58% | -97.06% | 79.22% | 71.57% |
| Normalized Basic EPS | 5.56% | 33.33% | 67.44% | 79.17% | 63.27% |
| EPS Diluted | 3.45% | 31.58% | -97.06% | 79.22% | 71.57% |
| Normalized Diluted EPS | 5.56% | 33.33% | 67.44% | 79.17% | 63.27% |
| Average Basic Shares Outstanding | 62.02% | 118.57% | 77.42% | 206.33% | 65.92% |
| Average Diluted Shares Outstanding | 62.02% | 118.57% | 77.42% | 206.33% | 65.92% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |